L'Hôtel-Dieu de Québec
10, rue McMahon
0881
Québec, Québec
Canada G1R 2J6

Dernières nouvelles

Information non disponible

58 enregistrements « 1 de 12 »

Fradet V, Toren P, Nguile-Makao M, Lodde M, Levesque J, Leger C, Caron A, Bergeron A, Ben-Zvi T, Lacombe L, Pouliot F, Tiguert R, Dujardin T, Fradet Y

Prognostic value of urinary prostate cancer antigen 3 (PCA3) during active surveillance of patients with low-risk prostate cancer receiving 5α-reductase inhibitors.

Article de revue

BJU Int, 121 (3), p. 399-404, 2018, ISSN: 1464-4096.

Résumé | Liens:

Koziolek M, Beige J, Wallbach M, Zenker D, Henning G, Halbach M, Mader N, Mahfoud F, Schlieper G, Schwenger V, Hausberg M, Borgel J, Lodde M, van der Giet M, Muller-Ehmsen J, Passauer J, Parmentier S, Luders S, Kramer BK, Buttner S, Limbourg F, Jordan J, Vonend O, Predel HG, Reuter H

[Baroreceptor activation therapy for therapy-resistant hypertension: indications and patient selection : Recommendations of the BAT consensus group 2017].

Article de revue

Internist (Berl), 58 (10), p. 1114-1123, 2017, ISSN: 0020-9554.

Résumé | Liens:

Simone G, De Nunzio C, Ferriero M, Cindolo L, Brookman-May S, Papalia R, Sperduti I, Collura D, Leonardo C, Anceschi U, Tuderti G, Misuraca L, Dalpiaz O, Hatzl S, Lodde M, Trenti E, Pastore AL, Palleschi G, Lotrecchiano G, Salzano L, Carbone A, De Cobelli O, Tubaro A, Schips L, Zigeuner R, Tostain J, May M, Guaglianone S, Muto G, Gallucci M

Trends in the use of partial nephrectomy for cT1 renal tumors: Analysis of a 10-yr European multicenter dataset.

Article de revue

Eur J Surg Oncol, 42 (11), p. 1729-1735, 2016, ISSN: 0748-7983.

Résumé | Liens:

Veccia A, Caffo O, De Giorgi U, Di Lorenzo G, Ortega C, Scognamiglio F, Aieta M, Facchini G, Mansueto G, Mattioli R, Procopio G, Zagonel V, D'Angelo A, Spizzo G, Bortolus R, Donini M, Lo Re G, Massari F, Vicario G, Zucali PA, Alesini D, Bonetti A, Mucciarini C, Nicodemo M, Berruti A, Fratino L, Lodde M, Messina C, Perin A, Santini D, Sava T, Tucci M, Basso U, Maines F, Burgio LS, Galligioni E

Clinical outcomes in octogenarians treated with docetaxel as first-line chemotherapy for castration-resistant prostate cancer.

Article de revue

Future Oncol, 12 (4), p. 493-502, 2016, ISSN: 1479-6694.

Résumé | Liens:

Trama A, Botta L, Nicolai N, Rossi PG, Contiero P, Fusco M, Lodde M, Pannozzo F, Piffer S, Puppo A, Seeber A, Tumino R, Valdagni R, Gatta G, Prostate Cancer High Resolution Study Working Group

Prostate cancer changes in clinical presentation and treatments in two decades: an Italian population-based study.

Article de revue

Eur J Cancer, 67 , p. 91-98, 2016, ISSN: 0959-8049.

Résumé | Liens:

58 enregistrements « 1 de 12 »